Behavioural Health Market is projected to expand at 3.4% CAGR over the forecast period of 2022-2028

According to the latest market report published by Future Market Insights titled “Behavioural Health Market: Global Industry Analysis 2013–2021 and Opportunity Assessment 2022–2028”, the global behavioural health market is expected to expand at 3.4% CAGR over the forecast period 2022-2028.

North America is expected to hold the highest revenue share in the global behavioural health market over the forecast period. Currently, over 43.8 million adults in the U.S. are suffering from mental illness, which is fuelling demand for behavioral health services. Developing economies are witnessing large demand for home care services, day care services, and internet-counselling services, which is further expected to boost revenue growth of the behavioural health market in emerging markets.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5375

Global Behavioural Health Market: Segmental Analysis & Forecast

The global behavioural health market is segmented based on service type, disorder type, and region. Based on service type the market is segmented into outpatient counselling, intensive case management, home-based treatment services, inpatient hospital treatment, emergency mental health service and others. The inpatient hospital treatment services type segment is expected to represent highest revenue share in the global behavioural health market. Home-based treatment services are expected to gain popularity among people in the coming years and this segment is expected to expand at a CAGR of 4.0% over the forecast period.

Based on disorder type the market is segmented into the anxiety disorder, bipolar disorder, depression, eating disorder, post-traumatic stress disorder (PSTD), substance abuse disorder and others. Among all disorder types, the anxiety disorder segment is anticipated to continue to lead the global behavioural health market due to a high patient pool globally and high adoption of behavioural health therapy among patients suffering from anxiety issues. According to the WHO, globally 260 million people are suffering from anxiety disorder.

Increased exposure to drugs and alcohol among young adults and strengthening insurance coverage policies for mental health are identified as key trends among end users in the global behavioural health market. Furthermore, rehabilitation programs for substance abuse disorder patients, outpatient counselling for ADHD affected children, and campaigns to spread awareness regarding mental disorders and drug addiction, etc. are some of the major factors that are driving the growth of the global behavioural health market. Government initiatives to reduce the burden of mental illness and rehabilitation services by non-government organizations (NGO) are further expected to positively impact revenue growth of the global behavioural health market.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-5375

Global Behavioural Health Market: Competition Analysis

The global market for behavioural health is fragmented with many local and regional level players operating in the worldwide market. Some of the key players featured in the global behavioural health market report include Acadia Healthcare Co., Inc., Universal Health Services Inc., Magellan Health Inc., National Mentor Holdings Inc., Behavioral Health Services Inc., Behavioral Health Network Inc., North Range Behavioral Health, Strategic Behavioral Health LLC, Seton Healthcare Family (Ascension Health) and Ocean Mental Health Services Inc. etc. among others.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-5375

Key Segments Covered in Behavioural Health Industry Survey

Behavioural Health by Service Type

  • Outpatient Counselling for Behavioural Health
  • Intensive Case Management for Behavioural Health
  • Home-based Treatment Services for Behavioural Health
  • Inpatient Hospital Treatment for Behavioural Health
  • Emergency Mental Health Service for Behavioural Health
  • Others

Behavioural Health by Disorder Type

  • Anxiety Disorder
  • ADHD
  • Bipolar Disorders
  • Depression
  • Eating Disorder
  • Post-traumatic Stress Disorder (PTSD)
  • Substance Abuse Disorder
  • Others

Behavioural Health Market by Region

  • North America Behavioural Health Market
  • Latin America Behavioural Health Market
  • Europe Behavioural Health Market
  • East Asia Behavioural Health Market
  • South Asia & Pacific Behavioural Health Market
  • Middle East & Africa (MEA) Behavioural Health Market

For more insights on the global market for behavioural health, write in to Future Market Insights analysts at press@futuremarketinsights.com

Stroke Assistive Devices Market Current Scenario Trends, Comprehensive Analysis and Regional Forecast to 2028

An assistive device, commonly, is a medical equipment that assists a disabled person or patients having inability to perform their daily tasks due to acute stroke or traumatic disorders. When a person encounters acute stroke, it becomes difficult for that patient to recover immediately from after effects of acute stroke that represents reduced mobility in limbs and extreme difficulties in performing their daily tasks such as dressing, bathing, grooming, cooking, feeding, etc. Thus, after having a stroke or trauma, most of the patients require assistive devices in order to maximize their independent functioning. In general, assistive devices find major applications for the disease indications including stroke, orthopedic, cognitive and motor skills, sports and others.

One of the most commonly used assistive device prescribed for stroke survivors is Mobility Assistive Devices (MAD). These mobility assistive devices for stroke patients offer improved mobility and allows them to independently perform the mobility-related tasks. A person who encountered stroke often has to undergo a long rehabilitation. Financed by the EU Research and Innovation programme Horizon H2020, robot-based technologies have been under substantial use to speed up the rehabilitation of stroke patients under its project called “the RETRAINER”. The technology used under this project allows the stroke patients to utilize their own arms and hands, as much and as soon, after the trauma or post-stroke in order to achieve best results in the rehabilitation.

After encountering stroke, a person usually goes to the physiotherapist for treatment or post-stroke recovery. The treatment may go wrong if the physiotherapist is not trained well, however, a patient receives quality treatment if these orthopedic treatment procedures are performed using robotic assistive devices. Stroke assistive devices are highly utilized in rehabilitation process to treat a physically disabled person in order to improve their daily performance. Thus, with the emergence of high incidence for stroke and trauma cases, stroke assistive devices experience greater demand from the end customers. Thus generating large revenues in the stroke assistive devices market.

Stroke assistive devices market on the basis of device type is classified into two main types – robotic exoskeletons, stroke-rehabilitation gloves, and others. Stroke rehabilitation is a treatment process solely targeted towards restoration of intellectual, physical, mental and social capabilities of a patient affected by stroke.

The growing incidence of stroke in U.S. population tends to be the leading reason to propel the growth of stroke assistive devices market across the globe. The growing adoption of stroke assistive devices by the physicians to treat post stroke effects is further anticipated to drive the demand for stroke assistive devices and thereby increasing revenue generation in stroke assistive devices market.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6921

Stroke Assistive Devices: Market Dynamics

Growing innovation and funding in neuromuscular & stroke rehabilitation, availability of high-tech and effective stroke assistive devices such as wearable wirelessly controlled rehabilitation device in the market, and growing population of stroke patients owing to increasing incidence of neuromuscular disorders and stroke across the globe is expected to be the key factor driving growth of stroke assistive devices market.

Rapid increase in physical disabilities caused due to increasing prevalence of disorders including spinal cord injury, rheumatoid arthritis, cerebral palsy and additional ageing disabilities is further expected to surge the demand for robotic rehabilitation and stroke-assistive technologies. Thus, the demand for stroke assistive devices has registered an upsurge, thereby generating more revenues in stroke assistive devices market. Also, growing mergers and acquisitions among the leading players in order to increase their geographical footprint is another factor propelling the growth of stroke assistive devices market.

However, lack of awareness among the people about new robotic technologies to assist stroke affected patient, particularly in the emerging economies, coupled with high cost of assistive technologies and robotic rehabilitation are some of the factors restraining the stroke assistive devices market growth.

Request Report Methodology: https://www.futuremarketinsights.com/askus/rep-gb-6921

Stroke Assistive Devices Market: Overview

Based on device type, robotic devices including robotic exoskeletons and stroke-rehabilitation gloves register the highest demand in the stroke assistive devices market owing to the better mobility results registered with usage of this device as compared to others. Stroke assistive devices found major usage in management of acute stroke and chronic neuromuscular disorders such as Multiple Sclerosis, Guillain Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Cerebral Palsy, and Muscular Dystrophy.

Rising number of disabled people due to the above mentioned disorders is one of the major factor driving the demand for stroke assistive devices for early management of patients effected with stroke, thereby fueling the stroke assistive devices market across the globe. However, the growing footprint of stroke assistive devices manufacturers for chronic disorders management applications coupled with rising demand for these devices is further expected to drive the revenue generation in global stroke assistive devices market.

Stroke Assistive Devices Market: Region-wise Outlook

On the basis of geography, global stroke assistive devices market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. Europe is projected to hold largest shares in the global stroke assistive devices market primarily due to increasing prevalence of disabilities in the region owing to growing incidence of stroke and neuromuscular disorders, enhanced healthcare infrastructure and increased R&D expenditure for manufacturing stroke-assistive devices. In Russia, about 13 million people are registered to live with certain post-stroke disabilities, constituting around 9% of the total Russian population. North America followed by Western Europe is expected to be the second dominating region in global stroke assistive devices market worldwide.

Stroke Assistive Devices Market: Key Players

Some of the key players present in global stroke assistive devices market are AnthroTronix, Inc., ReWalk Robotics, Mazor Robotics Ltd., Intuitive Surgical Inc., Interactive Motion Technologies, Bioxtreme Robotics Rehabilitation, Accuray, Inc., Health Robotics S.R.L., Ekso Bionics Holdings, Inc., and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-6921

Stroke Assistive Devices Market: Segmentation

The global stroke assistive devices market is segmented by device type and end user:

Segmentation by Device Type

  • Mobility Devices
  • Wheelchairs
  • Mobility Scooters
  • Walkers and Rollators
  • Cranes and Crutches
  • Transfer Lifts
  • Others
  • Robotic Aids
  • Robotic Exoskeletons
  • Stroke-Rehabilitation Gloves
  • Robotic Gait Trainers
  • Medical and Bathroom Assistive Devices
  • Shower Chairs and Tub Benches
  • Toilet Seats and Bedside Commodes
  • Other Bathing/Dressing Aids
  • Ostomy Products
  • Medical Beds
  • Reading and Vision Aids
  • Hearing Devices

Segmentation by End User

  • Hospitals
  • Specialty Clinics
  • Physiotherapy Centers
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others

Global Boron Trifluoride & Complexes Market Is Projected To Grow At A CAGR Of ~ 5% During The Forecast Period Of 2019-2029

The global boron trifluoride & complexes market sales are anticipated to be valued at ~US$ 233 Mn by the end of 2019, witnessing a strong Y-O-Y growth of ~4.5% over the year 2018, finds a recent study published by Future Market Insights. Asia Pacific excluding Japan is projected to hold more than half of the market value share by end of 2019 and grow with a significant CAGR in the near future, opines the study.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4067

Boron trifluoride is amongst the strongest Lewis acids (electron pair acceptor), and therefore, it finds application as a catalyst for a number of organic synthesis reactions including polymerization, alkylation, isomerization, and other chemical synthesis reactions.

A number of polymer derivatives are being made in the presence of boron trifluoride as a catalyst such as polypropylene and polyethylene. Boron trifluoride gas and its complexes are also being used for manufacturing rubber and other elastomeric polymers, which are increasingly being used across a number of end-use industries. Moreover, boron trifluoride is also used for the synthesis of different range of hydrocarbons such as aromatic hydrocarbons, unsaturated hydrocarbons, alcohols, phenols, and many others.

With growth in oil and gas and petrochemical industries in the region, through shale gas extraction, there has been tremendous growth in hydrocarbons synthesis and other chemicals, which use BF3 as a major catalyst during reaction. This, in turn, is driving the demand for boron trifluoride & complexes in the market, opines the FMI study.

The study also finds that the demand for boron trifluoride (BF3) gas and di ethyl etherate are anticipated to grow with significant CAGRs in terms of value during the forecast period. Furthermore, the applications of boron trifluoride & complexes as catalysts are projected to grow with a healthy CAGR owing to the huge demand generated from synthetic reactions such as polymerization, alkylation, isomerization, and other chemical synthesis.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-4067

Stringent Regulations on Manufacturing of Boron Trifluoride & Complexes Could Hinder Growth

Boron trifluoride, especially in the gaseous form, is considered to be a hazardous, toxic, and very corrosive substance. Therefore, there are a number of regulations pertaining to its manufacturing, transportation, labelling, exposure limit, labelling, and others.

Packaging and transportation of the gas is done under extremely high pressure and is a major challenge for manufacturers, distributors, and end users as well. Moreover, for using boron trifluoride in the gaseous form, there must be an appropriate unloading facility at the consumers’ end, which is leading to many of the end users using boron trifluoride in the complexes form. This factor is estimated to hinder the global boron trifluoride market by the end of the forecast period.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-4067

Boron Trifluoride & Complexes Market: Vendor Insights

The boron trifluoride & complexes market is fairly fragmented due to the presence of manufacturers at the regional level. Few of them included in the global boron trifluoride & complexes market report are – BASF SE, Air Liquide, Praxair Technology, Inc., Honeywell International Inc., Matheson Tri-Gas Inc., Gulbrandsen, Entegris, Inc., The Linde Group, Stella Chemifa Corporation, Hunan Heaven Materials Development Co., Arkema, ZIbo Shuanglian Petroleum & Chemical Co., Ltd., NAVIN FLUORINE INTERNATIONAL LIMITED, Qingzhou Chenkai Chemical Co., Ltd., ZIbo Shuanglian Petroleum & Chemical Co., Ltd., and Tanfac Industries Ltd.

Companies are focusing on mergers and acquisitions of big and small players in the market for expansion of sales and to gain competitive leverage over other players. For instance, in October 2016, the Honeywell International Inc. acquired the Research Chemicals Business from Sigma-Aldrich. The acquisition enabled the company to offer a broad line of inorganic chemicals and solvents for demanding applications.

Plant-Based Milk To Increase At 8.8% CAGR Between 2021 And 2031

Popularity of vegan diets can be attributed to popularity of veganism and rising focus on sustainable living. As per Future Market Insights (FMI), these factors will create conducive environment for the expansion of the plant based milk market. The report also forecasts the sales of plant-based milk to increase at 8.8% CAGR between 2021 and 2031.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13818

Concerns about the humane treatment of animals have also had a significant influence in the gradual shift toward vegan diets. The market for plant-based milk is predicted to expand as a result of these factors.

Consumers have become more appreciative of and inclined toward plant-based products, such as juices and other plant-based beverages, as health and wellness concerns have grown, due to the rise in prevalence of obesity, diabetes, and cardiovascular diseases.

Plant-based goods contribute to healthy eating habits by providing higher nutritional content, vitamins, minerals, and healthy fats. Veganism is gradually becoming more popular. Some of the countries have been identified to represent the trend from the fore at global forums. For instance:

  • In 2016, Singapore earned the spot of second-most vegan friendly Asian city by PETA Asia. Singapore was also titled the top 6th vegan city in the world by Happy Cow.
  • Hong Kong was listed in the top 10 vegan friendly countries by Peta Asia in 2020. According to a vegan business platform, Eco Warrior Princess, roughly 25% -70% of Hong Kong residents consume vegan meals.
  • Thailand witnessed the launch of several vegan restaurants and food outlets recently such as Veganerie, Vistro, May Veggie Home, and Swees among others.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-13818

Key Takeaways from the Plant-based Milk Market Study:

  • The U.S. is estimated to account for more than 80% of the North America market in 2021, supported by consumer awareness regarding nutritional foods.
  • According to FMI’s analysis, China is estimated to account for more than 60% of the Asia Pacific market in 2021, supported by easy availability of raw materials.
  • The U.K. is a high potential market in Europe, accounting for over 9.4% value share, supported by the popularity of clean label trends.
  • Sales via online retail are expected to grow at 10.8% CAGR through 2031.

“Consumers across the globe are becoming increasingly health-conscious. Increasing focus on health and wellness have been drawing them towards plant-based milk in comparison to regular diary. This also is encouraging the market players to put greater emphasis on product launches,” said a lead analyst at FMI. 

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-13818

Sustainability of Plant-based Milk Production to Increase its Appeal

Plant-based milk is popular among customers because of benefits it provides in terms of sustainability, nutrition, and convenience. Consumers now demand food & beverages that are good for both their bodies and environment.

There are various concerns with conventional dairy products, including inhumane livestock rearing & addition of pesticides and chemicals to dairy milk, among others. Because of its vegan origins and branding as a health product, demand for plant based milk such as oat milk is likely to increase.

Who is winning?

Manufacturers of plant-based milk are trying to attract customers by packaging their products in cartons which are creatively and beautifully crafted. It helps plant-based milk producers differentiate their beverage from the rest and draws more customers as buyers choose to purchase a more visually appealing product compared to a typical product.

Some of the leading companies offering plant-based milk are Groupe Danone, Alpina Foods, Blue Diamond Growers, Inc., Döhler GmbH, Earth’s Own Food Company Inc, Elden Foods Inc, Freedom Foods Group Ltd, Goya Foods, Groupe Danone, Hain Celestial Group, Inc, Kaslink Foods Oy Ltd, Living Harvest Foods Inc, Liwayway Holdings Company Limited, Mc Cormick & Co., Natura Foods, Nutriops SL, Organic Valley, Pacific Foods of Oregon, Inc, and others.

Varicella Zoster Infection Treatment Market Size 2022 Global Key Findings, Industry Demand, Regional Analysis, Key Players Profiles, Future Prospects and Forecasts to 2028

The global Varicella Zoster Infection Treatment Market in 2020 is estimated for more than US$ 1.5 Bn and expected to reach a value of US$ 2.0 Bn by 2028 with a significant CAGR of 4.1%. As per Future Market Insights’ projections, in 2022, the acyclovir holds a substantial share of over 55.7% in the overall varicella zoster infection treatment market.

Human alphaherpesvirus 3, also known as Varicella Zoster virus (VZV) is one of the many herpesviruses that is known to infect humans.  It is also the one causing infectious diseases like chicken pox (which is mostly common among children and teens) and herpes zoster (shingles) (mostly affecting adults but rarely in children).  The growing incidence of herpes zoster (shingles) infection among the children’s and the elderly and the rising demand towards the treatment of the infection is aiding the growth of the market.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-6466

For instance, in December 2016, Slayback and Sandoz signed an agreement with Novartis AG for the sale and marketing rights of Slayback Generic Zovirax Ointment (Acyclovir Ointment). Per the agreement Novartis obtained the sales and marketing rights, which increased their position in the market. Other leading companies operating in the market are Valeant Pharmaceuticals International Inc., Teva Pharmaceutical Industries Ltd, Pfizer Inc., Mylan N.V., Abbott Laboratories, GlaxoSmithKline Plc., and Dr. Reddy’s Laboratories Ltd., among others.

According to the report, the global varicella zoster infection treatment market is expected to register a 4.2% CAGR from 2017 to 2027. In 2016, the market was worth US$ 1,257.1 Mn and is expected to reach a valuation of US$ 1,969.1 Mn by the end of 2027.

Risk of Varicella in Pregnancy and the Need to Adhere to the Guidelines of Chickenpox Treatment to Bode Well for the Market 

Primary infection with varicella zoster in pregnancy may cause maternal mortality or serious morbidity issues. A particular guideline issued in 2015 assesses the evidence regarding maternal and foetal risks of varicella zoster virus infection in pregnancy. The U.K. Advisory Group and Swiss and Canadian national guidelines prescribe procedures for the use of antiviral drugs in pregnancy. The U.K. Advisory Group provides guidelines for chickenpox as well. These guidelines recommend oral acyclovir, which should be prescribed for pregnant women within 24 hours once they present the onset of the rash and if they have 20+0 weeks of gestation or beyond. Guidelines are unanimous nevertheless, in recommending that intravenous acyclovir be administered in cases of severe maternal infection. This factor along with the fact that the rate of exposure and transmission is extremely high in this infection and is a threat for pregnant women and kids, is expected to boost the growth of the varicella zoster infection treatment market.

Our advisory services are aimed at helping you with specific, customised insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-6466

Natural Products to Challenge Market Growth

Several people opt for other treatment options for herpes zoster and varicella. These alternative treatment options are expected to hamper the growth of the antiviral drugs market for varicella zoster infection treatment. Homeopathy, supplements, and other natural herbal medicines are used to treat herpes zoster and varicella.

Table Of Content

1. Executive Summary

2. Market Introduction

3. Varicella Zoster Infection Treatment Market Opportunity Analysis 

4. Market Background

5. Global Economic Outlook

6. Key Inclusions

Ask for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-6466

Contact Us:                                                      

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Automated Blood Processing Equipment Market Competitive Growth Strategies Based on Type, Applications, End User and Region

Automated blood processing equipment is used for the blood collection and processing of whole blood sample. The primary use of whole blood is as a source material for the preparation of blood components such as RBC (red blood cells), WBC (White blood cells), platelets, plasma and others components. The automated blood processing equipment helps to convert whole blood into different blood components, which are mostly used for the blood transfusion and others purposes.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-6712

Reduced human intervention with minimal contamination chances and shorten the duration of blood processing by reducing processing steps are the key benefits of the automated blood processing equipment. Hospitals and blood banks focus on to optimize throughput without increasing lab burden, expedite patient care and enhance laboratory efficiency through automated blood processing equipment. Automated blood processing equipment provides efficient outcomes, which facilitate diagnosis and treatment, reduce emergency room times with faster and reliable results than the traditional blood processing equipment.

Technology Advancement

Blood transfusion procedure can be helpful in various life-threating situations such as an accident or surgery, cancer therapy and disease (leukemia, myeloma, etc.). Manual collection and processing of whole blood should be carried out taking safety measures, but that would be time-consuming and contamination prone process. The main advantage of automated blood processing equipment include reduction of a number of equipment involved in blood component separation processing, overcome the laborious steps and standardize the quality of blood component. Healthcare facilities are more interested in automated blood processing equipment due to compact characteristics that lead to the reduction of workspace and increases production efficiency.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-6712

Rise in demand of safe and enhanced quality of blood components, increasing incidence of chronic diseases, strong campaigning for blood donation programs and growing healthcare spending are the key factors that drive the market growth over the forecast period. Technological advancements and development in donation screening test kits also play a vital role in the increasing demand for automated blood processing equipment. Changes in blood collection procedure and gradual migration of manual blood processing to automated processing machine are all poised to benefit the market growth. Also, the top manufacturers in the market are expanding the value chain to forward integrate the market in developing economies. In most of the developed countries, increasing investment in terms of healthcare spending and investment in healthcare facilities by government authorities are impelling the demand for automated blood processing equipment.

Regional Market Outlook

North America leads the automated blood processing equipment market owing to developed healthcare infrastructure, support from the government, and availability of advanced blood collection facilities. Western Europe is the second leading market for automated blood processing equipment due to increasing blood donation centers and blood transfusion sites that propel the demand. Increase in chronic diseases and surgical procedural volumes are also the leading factors that have raised the demand for pathogen-free blood and its components, which further increase the demand for automated blood processing equipment. The Asia Pacific excluding China and Japan market is also expected to grow at a higher rate owing to improving healthcare spending on capital equipment for enhancing automation in facilities and large target patient pool.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-6712

Competition Outlook

Some of the players identified in the global automated blood processing equipment market are Beckman Coulter, Inc, Fresenius Kabi AG, Terumo Corporation, Immucor, Macopharma., Grifol, and Others. The companies are focusing on innovating their automated blood processing equipment in order to reduce their manufacturing costs and compete in the market with reduced prices. Companies are opting for mergers and acquisitions as their growth strategy for expanding their geographic presence.

Small-Scale Manufacturers/Providers

  • Immucor
  • JMS Singapore Pte Ltd
  • MOELCA
  • LMB Technologie GmbH
  • Delcon SRL.

Medium-Scale Manufacturers/Providers

  • Baxter Healthcare
  • Macopharma
  • Grifols

Large-Scale Manufacturers/Providers

  • Beckman Coulter, Inc
  • Fresenius Kabi AG
  • Terumo Corporation

Key Data Points Covered in the Report

The report covers exhaustive analysis on:

  • Automated Blood Processing Equipment Market by product type, end-user and region
  • Regional level market analysis of North America, Latin America, Western Europe, Asia Pacific Excluding China & Japan, Japan, Middle East & Africa by product type, end-use segments and country
  • Automated Blood Processing Equipment Market Dynamics & Opportunity Assessment
  • Historical Actual Market Size, 2013 – 2017
  • Automated Blood Processing Equipment Market Size & Forecast 2018-2028
  • Automated Blood Processing Equipment Market Current Trends/Issues/Challenges
  • Competition & Companies involved

Research Methodology

The market sizing of automated blood processing equipment will be done by the installed-based triangulation approach. The demand-side approach will be followed to assess the actual market size of automated blood processing equipment. Secondary research will be used in the initial phase to identify the feasibility of the target services and its respective segments in end-use facilities and the future impact of new technologies. Each piece of information will be eventually analyzed during the entire research project, which helps build a strong base for the primary research information.

Primary research participants include demand-side respondents such as laboratory managers, procurement managers, hospitals, blood bank as well as key opinion leaders in addition to supply-side respondents such as equipment manufacturers who provide valuable insights on trends, research application of products and technologies, purchasing patterns, services offered and associated pricing.

Herpes Labialis Treatment Market 2022 by Global Key Players, Types, Applications, Countries, Industry Size and Forecast to 2028

The global Herpes Labialis Treatment Market is expected to register a CAGR of nearly 4.7% over the forecast period (2022-2028) owing to increasing cases of recurrent herpes simplex infections. The herpes labialis treatment market recorded sales worth U.S. $ 1.03 Bn in the year 2021 and is expected to reach U.S. $ 1.42 Bn by the year 2028, according to the Future Market Insights (FMI) study.

The herpes labialis treatment market accounts for nearly 2% of the market share by value of the overall Antiviral Drugs Market, which was valued at nearly US$ 52.7 Bn in the year 2020. The herpes labialis treatment market experienced an increase in the demand in the past few year owing to the rising prevalence of herpes labialis infections around the world. Herpes labialis is caused by herpes simplex virus (HSV), which primarily affects the lips and are alternatively called as cold sores. According to the World Health Organization’s 2020 statistics, approximately 3.7 million people suffered from HSV 1 infection globally.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-6461

North America to Maintain Leading Regional Market Position

Supported by strong presence of a few of the key industry players, North America’s herpes labialis treatment market is expected to continue its dominance throughout the forecast period. While this region registered over 35% value share, Western Europe recorded a share of over 20% in 2017. North American region is presumed to exceed the revenues worth US$ 450 Mn by the end of 2027, observing a declining CAGR of 3.9%. Although the US will lead the North American region, Future Market Insights projects that Canada will witness higher adoption of herpes labialis treatment in the assessment period.

On the flipside, emerging regional markets such as APEJ, MEA, Eastern Europe, and Latin America will see rapid growth in the forecast period. APEJ is identified to be the fastest growing market at a promising CAGR of 5.7%, followed by MEA, predicted to grow at 5.3% CAGR over 2017-2027. Strengthening efforts and accelerating investments in the examination of the clinical efficacy of drugs, increasing expenditure on R&D infrastructure, growing consumer awareness, and development of advanced, cost-effective treatment options at a rapid pace, will collectively lift the market in emerging countries up. Moreover, lenient FDI policies that govern the pharmaceuticals industry in developing economies prompt at the inflow of a series of opportunities for drug companies to explore these regional markets in near future.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-6461

Key Market Players

Some of the leading players competing in the global herpes labialis treatment market include Novartis AG, Valeant Pharmaceuticals International Inc., Pfizer Inc., Abbott Laboratories, Mylan NV, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and GlaxoSmithKline plc. A majority of key players are directing their efforts towards extension of existing product portfolio, while others are focusing on strategic mergers and acquisitions in order to grab larger market shares in terms of revenue. Many top brands are looking forward to capitalize on growing opportunities in emerging regional markets.

Functional Films Market Is Poised To Reach US$ 47.17 Mn By 2031

As per a study by Future Market Insights (FMI), increasing applications across diverse sectors, especially the printing and packaging industry will drive the functional films market between 2021 and 2032. Functional films are being steadily commercialized across various industries as they incorporate technologies to improve the functional performance of products on which functional films acts as substrate or a barrier.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-603

The market is gaining momentum, thanks to the expansion of the packaging and plastic industries. Their usage across automotive also is increasing. Functional films can be spotted in automotive displays, car interiors, transmission systems, and lighting.  In the packaging sector, BOPP films are the “go-to” options for lamination and flexible packaging purposes.

As per FMI, the functional films market is poised to reach US$ 47.17 Mn by 2031. The demand for both optical and coating films is considerably high. Of these, coatings films are expected to emerge dominant, exhibiting 8.7% CAGR over the forecast period.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-603

Key Takeaways of Functional Films Market Study

  • Application across various industries will continue driving functional films market at .2% CAGR through 2031
  • The U.S. remains the leading functional films market in North America, accounting for over 68% sales in 2021
  • After an insignificant year in 2020, the U.K. market will bounce back, registering a little below 6% y-o-y growth in 2021
  • Germany and France will remain key markets. Of these, Germany will remain dominant through the forecast period
  • Exceptional growth is likely in Japan, as it continues registering expansion of various end-use industries

“Functional films market, like any other sector, is heavily reliant on prevailing trends. Currently, there is high focus on sustainability especially as some of the leading players invest in environment-positive technologies,” said a lead analyst at FMI.

East Asia is expected to dominate the functional films global market. The intense activities in the region have stimulated market participants to engage in product innovations and steadily commercialize their products. In East Asia, the large demand owned by various end-use industries including consumer electronics and automotive, is likely favorable to mold the Functional Films market. The market growth is also dependent on various other factors such as raw material availability and large consumption base.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-603

Who is Winning?

Some of the leading companies operating in the functional films market include 3M, Dai Nippon Printing Co. Ltd, Toray industries Inc, SABIC, Covestro AG and Saint Gobain Films.

The functional films market is a highly competitive market dominated global petrochemical and chemical manufacturers and key players who are actively involved in the printing and packaging sector.  Some players are adopting backward integration, directly purchasing petrochemicals and manufacturing films from scratch. The market is also driven by regional players and new entrants who are aggressively involved to build their brand name.

The Tier-1 players hold approximately half the global value share. Drive for product positioning and collaboration are some of the common behavioral trends in the global market.

There is increasing focus on sustainability, especially some of the leading players. For instance, Coveris has built two new extrusion lines at Cheshire-based facility in Winsford, in the U.K. This capacity expansion is intended at supporting the company’s goal to achieve pack positive sustainability.

Zika Virus Testing Market 2022 by Global Key Players, Types, Applications, Countries, Industry Size and Forecast to 2031

The global zika virus testing market experienced a moderate incline, experiencing a CAGR of just above 2% between 2017 and 2020, being valued at a little over US$ 4 billion, as per ESOMAR-certified firm Future Market Insights (FMI) latest report on the landscape. Growth was majorly underpinned by the introduction of numerous point-of-care powerful testing approaches to facilitate timely detection of the virus.

According to FMI’s analysis, clinicians have been exhibiting a high preference towards enzyme linked immunosorbent assay (ELISA) tests. Compared to other immunoassay methods, ELISA tests are more accurate, are considered highly sensitive, specific and compare favorably with other methods used to detect substances in the body, such as radioimmune assay (RIA) tests.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/REP-GB-2913

Prominent players are experiencing immense growth opportunities across tropical regions, attributed to the high concentration rate of the zika virus across such regions as the Caribbean, Central America, Africa and the Asian sub-continent. Players such as EUROIMMUN have emerged at the forefront, being the first diagnostics company to provide a testing approach to detect the zika virus. Its product lines include the Anti-Zika Virus ELISA (IgA or IgG or IgM or IgAM) fully automatable test and the IIFT Arbovirus Fever Mosaic 2 (IgG or IgM) test.

Key Takeaways from FMI’s Zika Virus Testing Market Study

  • By test type, ELISA-based zika virus testing surpassed US$ 4 billion until 2020
  • By end-user, private commercial laboratories to remain primary point of contact for availing zika virus testing
  • Multiple regulatory approvals for various testing approaches by the FDA to bolster US zika virus testing market growth
  • Brazil to attract major zika virus testing providers amid increasing governmental initiatives to contain its spread
  • Growing focus on pregnant women’s health to accelerate testing volumes in Puerto Rico
  • UK to experience limited uptake amid the non-notifiable nature of the disease due to limited outbreaks

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-2913

Competitive Landscape

Prominent zika virus testing manufacturers are reliant on offering advanced testing approaches in order to yield quicker results so as to facilitate timely treatment. Besides, key research laboratories and organizations also emphasize on expanding their testing capabilities by virtue of strategic acquisition and collaboration agreements.

In 2017, the US FDA issued an Emergency Use Authorization (EUA) to authorize the RealStar® Zika Virus RT-PCR Kit for the in vitro qualitative detection of Zika virus with specified instruments. This test is offered by Altona Diagnostics GmbH, and tests presence of the virus in human serum, EDTA plasma and/or urine.

Similarly, ARUP Laboratories offers both serology and RT-PCR tests for detecting the zika virus. The former is called the Zika Virus IgM Antibody Capture (MAC) based on the ELISA technique. In the latter case, the test is conducted by collecting patients’ blood or urine samples.

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Buy Now Report@ https://www.futuremarketinsights.com/checkout/2913

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Rare Neurological Disease Treatment Market 2022 by Global Key Players, Types, Applications, Countries, Industry Size and Forecast to 2026

According to a newly published Future Market Insights report, the global rare neurological disease treatment market will exhibit a splendid expansion throughout the forecast period (2017-2026). Revenues from the market are envisaged to exceed US$ 12,000 Mn by 2026-end.

Declining blockbuster drugs are leading pharmaceutical industries to keenly investigate new avenues of research and development. Several drug manufacturers, incentivized by Orphan Drug Act, are developing new drug formulations pertaining to the treatment of rare diseases, in a bid to introduce new treatment options to the market. This has further influenced the development of drugs for treatment of rare neurological disorders. Regulatory advantages including breakthrough designations, reduced fees & tax incentives, and longer market exclusivity, are encouraging investments in the R&D of drugs apropos to rare neurological diseases.

Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6445

A new report of Future Market Insights offers forecast and analysis on the rare neurological disease treatment market on a global level. The report delivers actual data related to the market for the historical period (2012-2016) along with an estimated intelligence on the market for the forecast period (2017-2026). The information is presented in terms of value (US$ Mn). Macroeconomic indicators coupled with an outlook on the rare neurological disease treatment demand pattern around the world have also been encompassed by the report. The report further imparts key drivers and restraints for the global rare neurological disease treatment market, and their impact on regional segments included over the forecast period.

Report Structure

The executive summary chapter, which initiates the report, offers key market dynamics and numbers associated with the global rare neurological disease treatment market, along with key research findings related to the market segments comprised. The market numbers included in this chapter are a blend of compound annual growth rates, market shares, revenues, and volume sales.

A concise introduction to the rare neurological disease treatment market is offered in the chapter succeeding the executive summary, along with a formal definition of “rare neurological disease treatment”. Elaboration of the market dynamics that include future prospects, growth limitations & drivers, and trends has been delivered in the chapters subsequent to the overview. These chapters also inundate insights apropos to bottom line of enterprises in detail, along with the fiscal stimulus and the global economy.

Market Taxonomy

Region

  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA

Indication

  • Alzheimer’s Disease
  • Narcolepsy
  • Multiple Sclerosis
  • Amyotrophic Lateral Sclerosis
  • Other Indications

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-6445

Drug Type

  • Biologics
  • Organic Compounds

Mode of Administration

  • Injectables
  • Oral
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Competition Landscape

A complete package of intelligence on leading participants supporting expansion of the global rare neurological disease treatment market has been offered in the concluding chapter of this analytical research report. This chapter elucidates the competition landscape of the global market for rare neurological disease treatment, providing information on key strategy implementations of the market players, their product overview, key development, company overview, and key financials. A SWOT analysis on each market players has been provided in this chapter of the report.

Buy Report Now @ https://www.futuremarketinsights.com/checkout/6445

FMI’s report identifies and tracks key players influencing expansion of the rare neurological disease treatment market that include EMD Serono, Inc., Jazz Pharmaceuticals, Teva Pharmaceutical Industries Limited, Johnson & Johnson, Sanofi, Medtronic Plc, Bayer Aktiengesellschaft, and Novartis AG.

The geographical spread of the market players included, along with their future growth plans, intended mergers & acquisitions, overall revenues, and market shares are elaborated in detail in this chapter. The report has employed an intensity map for portraying key market players located across geographies.

Research Methodology

Credibility of researched statistics & data is backed by a unique research methodology used by analysts at FMI, ensuring high accuracy. This research report on global rare neurological disease treatment market can assist readers in acquiring detailed insights on several aspects that govern the market across the regional segments contained in the report. The report readers can use slated strategies to tap the vital revenue pockets, thereby gaining benefits over intensifying competition prevailing in the market. Intelligence presented in this report has been scrutinized & monitored thoroughly by FMI’s industry experts. The figures and numbers offered by the report are validated by the analysts for facilitating strategic decision making for market players.